US equities |
NVDA $239.97 ▲+0.45% SPCX $172.78 ▲+0.98% MU $1,065.49 ▲+0.14% MRVL $288.91 ▲+6.51% AMD $654.46 ▲+3.59% INTC $114.68 ▼-1.30% AVGO $379.22 ▲+4.61% TSLA $379.89 ▲+0.31%
FinancialContent

Medicus Pharma Ltd. - Common Stock (NQ:MDCX)

0.1595 -0.0075 (-4.49%)
Delayed Quote Updated: 1:48 PM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 646,350
Open 0.1654
Bid (Size) 0.1595 (49,600)
Ask (Size) 0.1600 (3,800)
Prev. Close 0.1670
Today's Range 0.1580 - 0.1694
52wk Range 0.1440 - 2.780
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA to Create Partner Ready Program in Advanced Prostate Cancer
Proposed seamless design would incorporate previously FDA-cleared dose-optimization work into a single registration-intent program aligning it with Company’s capital-efficient development strategy 
From Medicus Pharma Ltd
Via GlobeNewswire
News headline image
Medicus Pharma Announces Exclusive Development Focus for SkinJect® in Gorlin Syndrome Following Commercial, Clinical and Regulatory Assessment
Decision advances Company’s previously announced capital-efficient development strategy by concentrating resources on FDA-authorized, SKNJCT-005, NDA-enabling, Registrational Phase 2b Study in Gorlin... 
From Medicus Pharma Ltd
Via GlobeNewswire

Performance

52-Week Range 94.3% below 52-week high
0.1595
0.1452W Low 2.7852W High
1 Week 6.7% below 1-week high
0.151W Low 0.171W High

Medicus Pharma Ltd. - Common Stock (MDCX) traded between $0.14 and $2.78 over the past 52 weeks and last traded at $0.16, 94.3% below its 52-week high. Over the past week it ranged between $0.15 and $0.17.

Past 12 Months
+1.9%
-6.2%
-65.3%
-67.5%
-90.0%
-93.7%
1W +$0.00
1M -$0.01
3M -$0.30
6M -$0.33
YTD -$1.44
1Y -$2.36

MDCX was -93.7% over the past year, -67.5% over six months, -90.0% year to date, +1.9% in the last week.

12 Months vs Market
MDCX
-93.7%
DIA
+10.2%
SPY
+16.1%
QQQ
+25.2%
IWM
+14.1%

Over the past 12 months MDCX returned -93.7% versus DIA (Dow) +10.2%, SPY (S&P 500) +16.1%, QQQ (Nasdaq 100) +25.2% and IWM (Russell 2000) +14.1%.

Volume & Liquidity 0.15× 3-mo avg
Today 646,350 3-mo avg 4.3M
1W
1.4M
1M
5.3M
3M
4.3M
6M
4.2M
YTD
4.0M
1Y
3.1M

MDCX most recently traded 646,350 shares against a 3-month average daily volume of 4.3M.

More News

Read More
Unusual volume stocks are being observed in Thursday's session. ↗
Via Chartmill
News headline image
Medicus Pharma Publishes Abridged Final Phase 2 SkinJect® Clinical Study Report (CSR) Results Identifying 200 µg D-MNA Patch as the Lead Development Dose
From Medicus Pharma Ltd
Via GlobeNewswire
Unusual volume stocks in Tuesday's session ↗
Via Chartmill
News headline image
Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company
From Medicus Pharma Ltd
Via GlobeNewswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Check out the stocks that are attracting the most attention and driving market activity. ↗
Via Chartmill
Thursday's session: top gainers and losers ↗
Via Chartmill
Gapping stocks in Thursday's session ↗
Via Chartmill
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
Medicus Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
From Medicus Pharma Ltd
Via ACCESS Newswire
News headline image
Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom
From Medicus Pharma Ltd
Via GlobeNewswire
News headline image
Medicus Pharma Receives UAE Department of Health (DOH) Authorization to proceed with Novel Prospective Genomics Guided Precision Medicine Study Evaluating Teverelix® in Women with Endometriosis
From Medicus Pharma Ltd
Via GlobeNewswire
News headline image
Medicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registrational SkinJect® Study in Patients with Gorlin Syndrome
From Medicus Pharma Ltd
Via GlobeNewswire
News headline image
New to The Street to Broadcast Nationwide on Bloomberg Television Tonight at 6:30 PM ET Featuring RHINO Bitcoin, Marina Decisions, Medicus Pharma and Virtuix Holdings
From New to The Street
Via ACCESS Newswire
Top movers in Friday's after hours session ↗
Via Chartmill
News headline image
Medicus Pharma Receives Positive FDA Feedback and Central IRB Approval for Optimized Phase 2 Teverelix® Novel Study in Acute Urinary Retention
From Medicus Pharma Ltd
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
Curious about the stocks that are showing activity after the closing bell on Monday? ↗
Via Chartmill
News headline image
New to The Street Show #760 Airs Tonight on Bloomberg Television Across the U.S. on Independence Day Featuring Sullivan & Cromwell’s Frank Aquila, Medicus Pharma, PetVivo, FreeCast and YY Group
From New to The Street
Via ACCESS Newswire
News headline image
Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026
From Medicus Pharma Ltd
Via GlobeNewswire
News headline image
New to The Street broadcasts show #758 TODAY AT 6:30 PM ET on BLOOMBERG TELEVISION ACROSS THE UNITED STATES, LATIN AMERICA, AND MENA
From New to The Street
Via ACCESS Newswire
News headline image
Medicus Pharma Announces U.S. Food and Drug Administration (FDA) Submission of Rare Pediatric Disease Designation Request for SkinJect® in Gorlin Syndrome
From Medicus Pharma Ltd
Via GlobeNewswire
News headline image
New to The Street Broadcasting Saturday June 13th 630pm est ACROSS BLOOMBERG TELEVISION IN THE U.S., LATIN AMERICA, AND MENA
Via ACCESS Newswire

Frequently Asked Questions

Is Medicus Pharma Ltd. - Common Stock publicly traded?
Yes, Medicus Pharma Ltd. - Common Stock is publicly traded.
What exchange does Medicus Pharma Ltd. - Common Stock trade on?
Medicus Pharma Ltd. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Medicus Pharma Ltd. - Common Stock?
The ticker symbol for Medicus Pharma Ltd. - Common Stock is MDCX on the Nasdaq Stock Market
What is the current price of Medicus Pharma Ltd. - Common Stock?
The current price of Medicus Pharma Ltd. - Common Stock is 0.1595
When was Medicus Pharma Ltd. - Common Stock last traded?
The last trade of Medicus Pharma Ltd. - Common Stock was at 10/06/26 01:48 PM ET